By Ben Hirschler AMSTERDAM (Reuters) - Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood adequately. Reassuringly, the medicines were not associated with increased rates of either inflammation of the pancreas or cancer - something that has been a worry in the past. However, in the case of AstraZeneca and Bristol-Myers Squibb's approved drug Onglyza, there was a small increase in hospitalizations for heart failure. ... via Health News Headlines - Yahoo! News Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/09/doctors-get-good-and-bad-safety-news-on.html
No comments:
Post a Comment